Methods Eligibility criteria The PICOS strategy was defined as follows: P (participants) human subjects, I (interventions) oral LC treatment, C (comparisons) between supplementation and placebo, supplementation and control, or pre- and post- supplementation, O (outcomes) muscle variables, and S (study design) randomized controlled trials, non-randomized controlled trials, non-randomized non-controlled trials
El consumo alto de este aminocido puede derivar en un endurecimiento u obstruccin de las arterias, as como, enfermedades cardiovasculares
doi: 10.21873/anticanres.12508 164
10.1371/journal.pone.0078434 34 ClaesS
Liposomal Technology: For ingredients like glutathione, liposomal delivery is essential for bioavailability